Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADIDAS: Dapagliflozin in Heart Failure
NCT04707261Phase 4Recruiting
- Sponsor
- Xiangtan Central Hospital
- Start
- Aug 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in heart failure (HF), sponsored by Xiangtan Central Hospital. Started Aug 2021; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04707261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707261.